SCALE 14
INTESTINAL PERMEABILITY
CONTENTS
EXPLANATION
In approximately 114 readings, Edgar Cayce described
a pathophysiological condition involving a thinning of the walls of the
small intestine. This condition has come to be known as "leaky gut
syndrome" or excessive "intestinal permeability." With the walls
of the small intestine compromised, toxins that would normally be eliminated
through colon are absorbed through the gut wall and picked by the circulatory
system (especially the lymphatic circulation) to be distributed throughout
the body. If the toxins cannot be eliminated through the other channels
of elimination (such as urination or respiration), the skin becomes the
last outlet of elimination (perspiration). Thus, skin disorders (such
as psoriasis) may result from excessive intestinal permeability and poor
eliminations.
Several factors can contribute to excessive intestinal
permeability. Pressures on nerve centers (especially in the mid thoracic
region) which innervate the intestines was cited in numerous readings.
Cayce observed that depleted nerve energy to the intestines weakened the
lining of the gut allowing toxins to leak through. Hyperacidity in
the bowel was also mentioned as a contributing cause of excessive intestinal
permeability.
The
link between psoriasis and intestinal permeability has been discussed in
the medical literature as documented below.
THERAPEUTIC OPTIONS
DIET
The basic Cayce diet is based primarily on fresh
fruits and vegetables. Certain foods (which tend to increase intestinal
toxicity) must be eliminated from the diet. Taboo items include red
meat, fried foods, carbonated and alcoholic beverages, and dairy products
that are not low fat. Dr. John Pagano has also identified the nightshade
group of vegetables (tomatoes, tobacco, eggplant, peppers, white
potatoes, and paprika) as particularly harmful for persons with psoriasis.
DIETARY SUPPLEMENTS
Certain herbal teas were frequently recommended by
Edgar Cayce in cases involving "leaky gut."
The most frequently suggested herbal teas suggested are: American Yellow
Saffron (not Spanish)
and Slippery Elm Bark Powder. At times, Chamomile, Mullein and/or
Watermelon Seed Tea may be used as a substitute for the American Yellow
Saffron. The purpose of these teas is to heal the porous thin intestinal
walls, as well as flush out the liver and kidneys of toxic elements.
Small doses of olive oil taken during the day were
also frequently recommended for excessive intestinal permeability.
A typical dosage was for a quarter to half a teaspoonful every three or
four hours during the waking period for three or four days and then rest
for three for four days before repeating the cycle.
MANUAL THERAPY
One of the primary causes of thinned intestinal walls
identified by Edgar Cayce is problems with the spine. Pressures on
certain spinal nerves (particularly the mid dorsal area) can compromise
the nerve energy to the intestinal tract. Osteopathic or chiropractic
treatment can help correct the misalignment of spinal vertebrae and improve
nerve functioning.
HYDROTHERAPY
Hydrotherapy includes drinking six to eight glasses
of pure water daily. Enemas or preferably, colonic irrigations may
be helpful in eliminating toxins from the bowel which may be contributing
to excessive permeability and systemic toxicity.
FURTHER ASSESSMENT
Options for further assessment include:
-
Intestinal Permeability Test
-
Great Smokies Diagnostic Laboratory
-
63 Zillicoa Street
-
Asheville, NC
-
(704) 253-0621
DOCUMENTATION
SCALE 14: INTESTINAL PERMEABILITY
SYMPTOM
|
READINGS
|
Skin blemishes |
3112-1, 3032-1, 2884-3, 982-1, 641-5, 475-1, 289-2 |
Swollen or painful joints (arthritis or rheumatism) |
5681, 4989-1, 1620-3, 908-1 |
Indigestion or stomach or intestinal gas |
5681-1, 4433-1, 3866-1, 982-1, 349-16 |
Tender spots or painful areas over the body |
1620-3, 982-1, 644-1 |
Nasal congestion (catarrh) or sinus problems |
5434-1, 3866-1, 3794-1, 622-1, 289-2 |
Headache |
4433-1, 4387-1, 3776-4, 641-7 |
Depression |
4433-1, 3794-1, 982-1 |
Constipation |
4387-1, 1620-3, 982-1, 622-1, 566-2, 349-16, 294-21 |
MEDICAL RESEARCH
ON THE INTESTINE/PSORIASIS CONNECTION
INTESTINAL PERMEABILITY
Edgar Cayce is not alone in recognizing that toxins
leaking from the intestines are involved in
psoriasis. Several researchers have written on this subject in
the medical journals. Here is a brief summary of that literature.
Humbert, et al. (1991), notes, "A possible
relationship between intestinal structure and function in
the pathogenesis of psoriasis has recently brought about considerable
interest." They studied the
intestines of 15 psoriatic patients and 15 healthy subjects and concluded,
"The difference in
intestinal permeability between psoriatic patients and controls could
be due to alterations in the
small intestinal epithelium of psoriatics." (p. 324)
Person and Bernhard (1986) note that the "pustular
dermatitis associated with small bowel
bypass surgery and the cutaneous manifestations of inflammatory
bowel disease are well known
and generally assumed to be due to the absorption
of microbial antigens from the bowel." They
hypothesize that the association of intestinal and dermatological pathology
"may be the result of
minor perturbations of mucosal permeability or the
failure of locally produced dimeric serum
IgA to inactivate bacterial or dietary antigens. Such disparate
entities as Reiter's syndrome,
psoriasis, pyoderma gangrenosum, and ankylosing spondylitis, as well
as the pustular
eruptions of Behcet's syndrome, pustular psoriasis, and lithium therapy,
may share this
common pathogenesis." (p. 559) This particular research approach
is an excellent example of
comorbidity and nonspecificity. In other words, the same cause may
produce a variety of symptoms
and syndromes.
Yates, Watkinson, and Kelman (1982) also note comorbidity
and nonspecificity in an article
titled, "Further Evidence for an Association Between
Psoriasis, Crohn's Disease, and Ulcerative
Colitis." To test the hypothesis that these three illnesses are
related, they studied 204 patients with
inflammatory bowel disease (116 with Crohn's disease and 88 with ulcerative
colitis) and 204 age-
and sex-matched controls. Although their research did not directly
address the question of intestinal
permeability, they did conclude: "The prevalance of psoriasis in Crohn's
disease (11.2%) and in
ulcerative colitis (5.7%) was significantly greater than in the control
group (1.5%). The prevalence of
psoriasis in first-degree relatives of patients with inflammatory bowel
disease was also increased. It
is suggested that there is a relationship between psoriasis, ankylosing
spondylitis, sacroiliitis,
peripheral arthropathy and inflammatory bowel disease, which may be
explained by common genetic
factors." (p. 323)
REFERENCES AND SELECTED BIBLIOGRAPHY
Barry, R. M., Salmon, P. R. & Read, A. E. (1971).
Small Bowel Mucosal Changes in Psoriasis.
Gut, 12(6), p. 495.
Barry, R. E., Salmon, P. R., Read, A. E. & Warin, R. P. (1971).
Mucosal Architecture of the
Small Bowel in Cases of Psoriasis. Gut, 12(11), pp. 873-877.
Bedi, T. R., Bhutani, L. K., Kandhari, K. C. & Tandon, B. N.
(1974). Small Bowel in Skin
Diseases. Indian Journal of Medical Research, 62(1),
pp. 142-149.
de Vos, R. J., de Boer, W. A. & Haas, F. D. (1995).
Is There a Relationship Between Psoriasis
and Coeliac Disease? Journal of Internal Medicine, 237(1), p.
118.
Fry, L. (1970). The Gut and the Skin. Postgraduate
Medical Journal, 46(541), pp. 664-670.
Humbert, P., Bidet, A., Treffel, P., Drobacheff, C. & Agache, P.
(1991). Intestinal Permeability in
Patients with Psoriasis. Journal of Dermatological Science,
2(4),
pp. 324-326.
Madanagopalan, N., Shantha, M., Rao, U. P. & Thambiah, A. S.
(1973). Peroral Jejunal
Mucosal Biopsy in Dermatological and Some Non-diarrhoeal Diseases.
Australian Journal of
Dermatology, 14(1), pp. 47-52.
Marks, J. & Shuster, S. (1971). Intestinal Malabsorption
and the Skin. Gut, 12(11),
pp. 938-947.
Marks, J. & Shuster, S. (1971). Psoriatic Enteropathy.
Archives of Dermatology, 103(6),
pp. 676-678.
Moll, J. M., Haslock, I., Macrae, I. F. & Wright, V. (1974).
Associations Between Ankylosing
Spondylitis, Psoriatic Arthritis, Reiter's Disease, the Intestinal
Arthropathies, and Behcet's
syndrome. Medicine, 53(5), pp. 343-364.
O'Laughlin, J. C. & Di Giovanni, A. M. (1979). Psoriatic
Enteropathy: Report of Case and Review
of Literature. Journal of the American Osteopathic Association,
79(2), pp. 107-111.
Person, J. R. & Bernhard, J. D. (1986). Autointoxication
Revisited. Journal of the Americal
Academy of Dermatology, 15(3), pp. 559-563.
Salmon, P. R., Read, A. E. & Warin, R. (1969). Radiocarbon
Estimation of Lactose Absorption:
A Survey of 104 Patients with Skin Disease. Gut, 10(12), p. 1052.
Shuster, S. (1968). Dermatogenic Enteropathy. New
York State Journal of Medicine, 68(24), pp.
3160-3165.
Summerly, R. & Giles, C. (1971). Question of Psoriatic
Enteropathy. Archives of Dermatology,
103(6), pp. 678-679.
Yates, V. M., Watkinson, G. & Kelman, A. (1982). Further
Evidence for an Association
Between Psoriasis, Crohn's Disease and Ulcerative Colitis. British
Journal of Dermatology, 106(3),
pp. 323-330.